Lyons-Williams Lori

Lyons-Williams Lori is listed in filings as Director at Contineum Therapeutics, Inc. Class A Common Stock. This profile follows SEC Form 4 activity through Jun 26, 2025, including 1 public disclosure. Recent filings connect the profile to Contineum Therapeutics, Inc. Class A Common Stock (CTNM). The current snapshot covers public activity from Jun 26, 2025. Reported amounts are shown as $59.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.